Benefits
UTI Prevention (Multiple RCTs)
Multiple Pacran RCTs demonstrate reduced UTI incidence in women with recurrent UTIs. 500 mg/day Pacran has clinical evidence for urinary tract health support.
A-Type Proanthocyanidins (PACs)
Cranberry's unique A-type PACs prevent E. coli adhesion to bladder wall — primary UTI prevention mechanism. Whole cranberry provides PAC plus additional cranberry compounds.
Frequent Urination Support in Women
Recent Pacran research established benefits for alleviating frequent urination in women.
Whole Cranberry Distinction
Pacran uses whole cranberry providing comprehensive phytochemistry — A-type PACs PLUS organic acids, flavonoids, anthocyanins.
Convenient Daily Dosing
500 mg single-capsule daily dose convenient for consistent urinary health support.
Mechanism of action
A-Type PAC Anti-Adhesion
Cranberry's unique A-TYPE PACs (most berries have B-type) prevent type-1 fimbriated E. coli adhesion to bladder uroepithelium. Without adhesion, bacteria cannot establish infection.
Bacterial Adhesion vs Antimicrobial
Cranberry doesn't kill bacteria — prevents adhesion. Mechanism distinct from antibiotics. Supports bacteria flushing via urination.
Whole Cranberry Phytochemistry
Beyond PACs: organic acids may modify urine pH; flavonoids provide antioxidant; comprehensive cranberry profile.
Clinical trials
Multiple Pacran 500 mg/day RCTs in women with recurrent UTIs.
Women with recurrent UTIs.
Reduced UTI incidence vs placebo across studies.
Recent clinical study of Pacran for alleviating frequent urination in women.
Women with frequent urination.
Improvements in frequency markers; established additional women's urological applications.
About this ingredient
PACRAN® is a WHOLE CRANBERRY POWDER (VACCINIUM MACROCARPON) developed by NATUREX (now GIVAUDAN). CRANBERRY BACKGROUND: native to North America; long traditional use for urinary tract health; primary mechanism via UNIQUE A-TYPE PROANTHOCYANIDINS (PACs) that prevent E. coli adhesion to bladder wall.
KEY DISTINCTIONS: (1) WHOLE CRANBERRY POWDER vs PAC-only extracts; (2) Comprehensive cranberry phytochemistry; (3) Multiple clinical RCTs for UTI prevention; (4) Recent women's urological research; (5) Single 500 mg daily dose convenient; (6) Naturex/Givaudan quality.
EVIDENCE-BASED USES: (1) UTI PREVENTION in women with recurrent UTIs; (2) FREQUENT URINATION support in women; (3) Urinary tract health maintenance; (4) Women's urological health.
CRITICAL CAUTIONS: (1) NOT FOR ACUTE UTI TREATMENT — Pacran is for PREVENTION; established UTIs require antibiotic treatment; symptoms (burning, urgency, frequency, fever) warrant medical evaluation; (2) RECURRENT UTI POPULATION — most evidence in women with HISTORY of recurrent UTIs; less evidence in occasional UTI; (3) DOSE — 500 mg/day Pacran research-validated; consistent daily use for prevention; (4) WARFARIN — historical interaction concern less significant than thought based on recent evidence but consult; (5) OXALATES — cranberry contains oxalates; relevant for those with oxalate kidney stone history; consult; (6) PACRAN vs CRANBERRY JUICE — concentrated standardized form vs juice (sugar content, varies in PAC content); Pacran provides reliable PAC dose; (7) PACRAN vs PAC-ONLY EXTRACTS — whole cranberry vs PAC-focused; both have evidence; whole cranberry comprehensive approach; (8) PREGNANCY — cranberry generally considered safe; some pregnant women use for UTI prevention; consult prenatal care; (9) CHILDREN — cranberry generally safe at proportional doses; UTI prevention in pediatric populations sometimes used; (10) MEN'S USE — most evidence in women but mechanism applies to men; less common UTI population; (11) ANTIBIOTIC ADJUNCT — Pacran can be used alongside antibiotic prophylaxis or as alternative; consult; (12) BRAND VERIFICATION — Pacran® is Naturex/Givaudan trademark; specific clinical evidence on this branded form; (13) MOST EVIDENCE-BASED CRANBERRY ingredient for UTI prevention applications.